Audacia Bio
  • COVID-19
  • Products
  • About Us
  • Contact Us
Picture

An Ontario-based biomedical company specializing in the development of testing and the deployment of data-driven protocols for decision making to respond to Covid-19 through diagnostics.

We believe the combination of testing and technology can provide us with the necessary data/information to serve as a roadmap to navigate through the pandemic and serve our community.
Study Dashboard
COVID-19 Clinical Trials and Research Studies
Audacia Bioscience
Data Collection Apps (IOS & Android)
Audacia Bioscience
Compliant IRB/REB Documentation
Audacia Bioscience
Hippa & 21CRF Part 11 Compliant
Audacia Bioscience
COVID 19 Rapid Test (Antigen and Antibody)
​Audacia Bioscience will lead with advanced knowledge and its application collectively while utilizing biochemistry, data collection tools, manufacturing, healthcare, education and industry

We have developed products based on key stages of the disease and the associated care. This serves as a foundation to establish a matrix in decision making

Private-public partnerships with Henry Ford Healthcare System, Institute for Border Logistics and Security, Windsor Regional Hospital, University of Windsor, St. Clair  College and more have produced a number of technology innovations to assist in the data collection around COVID-19
  • An app for healthcare workers to enter data without paper and pen on approved devices.​
  • Virtual screening tool for individuals to assess their risk levels to evaluate the severity of Covid-19 if contracted.​
  • No contact screening tool for corporate management to identify employee wellness and risk to make informed decisions and implement health and safety protocols.
Picture

We strive to ensure remote data collection and research is safe, simple and ubiquitous. 

The Audacia Bioscience team brings together science, technology and medicine to support a collective commitment to the region to develop solutions to the Covid-19 pandemic.

Diagnostic Products



Our team has proudly built a predominantly Canadian supply chain that provides the necessary materials and components to develop efficient solutions to COVID-19 research.

  • Pre-infectious:
    Saliva test (PCR) - We are currently validating several saliva infection kits and working toward regional partnerships to encourage testing turnaround times, wait times and response times in our community.




  • Infectious:
    Antigen tests are used to quickly identify infectious people.  Our  CAG-19D Colloidal Gold Antigen Test is CE approved and works to identify the immediate infection stage of the virus.








  • Post-infectious:
    Antibody tests are used to understand the prevalence of the disease.  Our CMD-19D Antibody test detects the presence of antibodies post infection.
Audacia Bioscience
Picture
Picture

Real-Time Dashboards

Audacia Bioscience

​All of our studies and trials benefit from continual access to the study data. This allows study coordinators to obtain key metrics and insights to monitor the performance. Reports can be extracted or data transferred to your clinical system, or analyzed and exported for further use.

 We are committed to the wellness of our region and the communities where we live and work. The advancement of  our development and technology has a keen interest in producing positive outcomes for the people of Windsor-Essex that can be shared with the world.

Taking the knowledge gained, Audacia Bioscience identifies and seeks the best partners to work with us to develop relevant tools that meet the needs of communities, companies and institutions.
Picture
Picture
Picture
Picture
Picture

About Us

Contact Us

© COPYRIGHT 2019. ALL RIGHTS RESERVED.

  • COVID-19
  • Products
  • About Us
  • Contact Us